Continuous Data Collection and Analysis for Stroke Prevention Using a Wearable Sensor
- Conditions
- Atrial Fibrillation
- Interventions
- Device: Amiigo Watch OnlyDevice: Amiigo Watch + BodyGuardian
- Registration Number
- NCT03441022
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this study is to determine whether a wristband that detects your pulse can detect your heart rate and rhythm similar to electrocardiograms (ECG).
- Detailed Description
The purpose of this study is to determine whether a wristband that detects your pulse can detect your heart rate and rhythm similar to electrocardiograms (ECG). These wristbands detect your pulse based on a technique called "photoplethysmography," (PPG). PPG is a common method in which an individual's pulse is detected based on a light signature interpreted by the wristband. Most commercially available heart rate monitors use PPG to determine your heart rate, but the accuracy is variable.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Male or female 18 years of age or older with a primary diagnosis of atrial fibrillation
- Willing and able to provide informed consent and follow the study protocol
- Clinically indicated planned restoration of normal rhythm
- Unable to provide informed consent
- Unable to follow the study protocol
- Women who are pregnant
- Subjects with implantable devices (only if participating in phase 2-BodyGuardian processes/testing)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Cardioversion Amiigo Watch + BodyGuardian Amiigo watch during atrial fibrillation cardioversion. Optional sub-study: additional 30 days wearing Amiigo watch as well as BodyGuardian device. Cardioversion Amiigo Watch Only Amiigo watch during atrial fibrillation cardioversion. Optional sub-study: additional 30 days wearing Amiigo watch as well as BodyGuardian device.
- Primary Outcome Measures
Name Time Method Watch Accuracy compared to BodyGuardian 30 days Determine the accuracy of ambulatory photoplethysmography for detection of heart rhythm when compared with a wearable clinically available 30 day monitor (BodyGuardian) in terms of accuracy of AF detection.
Watch Accuracy during Cardioversion Duration of cardioversion procedure Determine whether the R-R interval estimate from artifact-free non-invasive photoplethysmography sample waveform segments is a reasonable basis for a atrial fibrillation (AF) detection algorithm as compared to a gold standard measurement from ECG in the acute cardioversion setting
- Secondary Outcome Measures
Name Time Method